[go: up one dir, main page]

GB0920933D0 - Agent for treating disease - Google Patents

Agent for treating disease

Info

Publication number
GB0920933D0
GB0920933D0 GB0920933A GB0920933A GB0920933D0 GB 0920933 D0 GB0920933 D0 GB 0920933D0 GB 0920933 A GB0920933 A GB 0920933A GB 0920933 A GB0920933 A GB 0920933A GB 0920933 D0 GB0920933 D0 GB 0920933D0
Authority
GB
United Kingdom
Prior art keywords
agent
treating disease
disease
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0920933A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest AG
Original Assignee
Biotest AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest AG filed Critical Biotest AG
Priority to GB0920933A priority Critical patent/GB0920933D0/en
Publication of GB0920933D0 publication Critical patent/GB0920933D0/en
Priority to US13/512,712 priority patent/US8956607B2/en
Priority to BR112012012912A priority patent/BR112012012912A2/en
Priority to JP2012541469A priority patent/JP6005519B2/en
Priority to NZ600899A priority patent/NZ600899A/en
Priority to MX2012006197A priority patent/MX350206B/en
Priority to PCT/EP2010/068562 priority patent/WO2011064398A1/en
Priority to EP10788050.2A priority patent/EP2470209B1/en
Priority to KR1020127016863A priority patent/KR101802261B1/en
Priority to CA2782004A priority patent/CA2782004A1/en
Priority to KR1020127016884A priority patent/KR101802260B1/en
Priority to EP10785417A priority patent/EP2470208A1/en
Priority to RU2012127381/10A priority patent/RU2587622C2/en
Priority to MX2012006198A priority patent/MX343228B/en
Priority to SG10201407935YA priority patent/SG10201407935YA/en
Priority to JP2012541466A priority patent/JP2013511994A/en
Priority to US13/512,780 priority patent/US8852871B2/en
Priority to AU2010323037A priority patent/AU2010323037B2/en
Priority to PCT/EP2010/068569 priority patent/WO2011064399A1/en
Priority to CN201080062123.8A priority patent/CN102711829B/en
Priority to RU2012127380/10A priority patent/RU2581812C2/en
Priority to AU2010323036A priority patent/AU2010323036B2/en
Priority to CN201080062098.3A priority patent/CN102811736B/en
Priority to NZ600894A priority patent/NZ600894A/en
Priority to BR112012012917A priority patent/BR112012012917A2/en
Priority to SG10201407936XA priority patent/SG10201407936XA/en
Priority to CA2782007A priority patent/CA2782007C/en
Priority to IL219955A priority patent/IL219955A/en
Priority to IL219954A priority patent/IL219954A/en
Priority to CR20120359A priority patent/CR20120359A/en
Priority to ZA2012/04843A priority patent/ZA201204843B/en
Priority to CR20120358A priority patent/CR20120358A/en
Priority to CO12109341A priority patent/CO6561779A2/en
Priority to US14/473,186 priority patent/US9605066B2/en
Priority to US14/591,133 priority patent/US9540436B2/en
Ceased legal-status Critical Current

Links

GB0920933A 2009-11-30 2009-11-30 Agent for treating disease Ceased GB0920933D0 (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
GB0920933A GB0920933D0 (en) 2009-11-30 2009-11-30 Agent for treating disease
CA2782007A CA2782007C (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
US13/512,780 US8852871B2 (en) 2009-11-30 2010-11-30 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
AU2010323037A AU2010323037B2 (en) 2009-11-30 2010-11-30 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
JP2012541469A JP6005519B2 (en) 2009-11-30 2010-11-30 Humanized anti-IL-10 antibody for treating systemic lupus erythematosus (SLE)
NZ600899A NZ600899A (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
MX2012006197A MX350206B (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle).
PCT/EP2010/068562 WO2011064398A1 (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
EP10788050.2A EP2470209B1 (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
KR1020127016863A KR101802261B1 (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
CA2782004A CA2782004A1 (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
KR1020127016884A KR101802260B1 (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
EP10785417A EP2470208A1 (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
RU2012127381/10A RU2587622C2 (en) 2009-11-30 2010-11-30 Humanised anti-il-10 antibodies for treating systemic lupus erythematosus (sle)
MX2012006198A MX343228B (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle).
SG10201407935YA SG10201407935YA (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
JP2012541466A JP2013511994A (en) 2009-11-30 2010-11-30 Humanized anti-IL-10 antibody for treating systemic lupus erythematosus (SLE)
US13/512,712 US8956607B2 (en) 2009-11-30 2010-11-30 Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)
PCT/EP2010/068569 WO2011064399A1 (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
BR112012012912A BR112012012912A2 (en) 2009-11-30 2010-11-30 antibody or fragment thereof, nucleic acid, vector, host cell, method for producing an antibody or fragment thereof, pharmaceutical composition, method for treating or preventing a medical condition in an individual, use of an antibody or fragment thereof and in vitro methods for neutralizing il-10 in a sample and detecting the presence of il-10 in a sample.
CN201080062123.8A CN102711829B (en) 2009-11-30 2010-11-30 The anti-IL-10 antibody of humanization of systemic lupus erythematosus (SLE)
RU2012127380/10A RU2581812C2 (en) 2009-11-30 2010-11-30 Humanised anti-il-10 antibodies for treating systemic lupus erythematosus (sle)
AU2010323036A AU2010323036B2 (en) 2009-11-30 2010-11-30 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
CN201080062098.3A CN102811736B (en) 2009-11-30 2010-11-30 The anti-IL-10 antibody of humanization of systemic lupus erythematosus (SLE)
NZ600894A NZ600894A (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
BR112012012917A BR112012012917A2 (en) 2009-11-30 2010-11-30 antibody, nucleic acid, vector, host cell, method for producing an antibody or fragment thereof, pharmaceutical composition, method for treating or preventing a medical condition in an individual, use of an antibody or fragment thereof, and methods in vitro to neutralize il-10 in a sample, in vitro to detect the presence of il-10 in a sample and to diagnose systemic lupus erythematosus (sle) in an individual
SG10201407936XA SG10201407936XA (en) 2009-11-30 2010-11-30 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
IL219954A IL219954A (en) 2009-11-30 2012-05-23 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
IL219955A IL219955A (en) 2009-11-30 2012-05-23 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
CR20120359A CR20120359A (en) 2009-11-30 2012-06-28 ANTI-IL-10 HUMANIZED ANTIBODIES FOR THE TREATMENT OF ERYTHEMATE SYSTEM LUPUS (SLE)
ZA2012/04843A ZA201204843B (en) 2009-11-30 2012-06-28 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
CR20120358A CR20120358A (en) 2009-11-30 2012-06-28 ANTI-IL-10 HUMANIZED ANTIBODIES FOR THE TREATMENT OF ERYTHEMATE SYSTEM LUPUS (SLE)
CO12109341A CO6561779A2 (en) 2009-11-30 2012-06-29 ANTI-IL 10- HUMANIZED ANTIBODIES FOR THE TREATMENT OF ERYTHEMATE SYSTEM LUPUS (SLE)
US14/473,186 US9605066B2 (en) 2009-11-30 2014-08-29 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
US14/591,133 US9540436B2 (en) 2009-11-30 2015-01-07 Use of antibodies for detection of IL-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0920933A GB0920933D0 (en) 2009-11-30 2009-11-30 Agent for treating disease

Publications (1)

Publication Number Publication Date
GB0920933D0 true GB0920933D0 (en) 2010-01-13

Family

ID=41572896

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0920933A Ceased GB0920933D0 (en) 2009-11-30 2009-11-30 Agent for treating disease

Country Status (1)

Country Link
GB (1) GB0920933D0 (en)

Similar Documents

Publication Publication Date Title
IL207892A0 (en) Agent for treating disease
HK1151533A1 (en) Agent for treating disease
ZA201007215B (en) Agent for treating disease
EP2464219A4 (en) Multi-transgenic pigs for diabetes treatment
HK1169941A1 (en) Compositions for treating peripheral vascular disease
ZA201505556B (en) Compositions for treating gaucher disease
EP2409634A4 (en) Endoscope for treatment
GB0802116D0 (en) Treatment
EP2365747A4 (en) Methods for treating gastrointestinal diseases
IL220526A0 (en) Kokumi-imparting agent
ZA201204845B (en) Agents for treating disease
IL220527A0 (en) Kokumi-imparting agent
HK1154797A1 (en) Composition for treating disease
GB0900599D0 (en) Treatment
GB0900484D0 (en) Therapeutic agent
EP2410846A4 (en) Glycolipids as treatment for disease
ZA201009226B (en) Nifurtimox for treating disease caused by trichomonadida
GB201013898D0 (en) Well treatment
EP2601954A4 (en) Therapeutic agent for disease
ZA201201894B (en) Pharmaceutical combination for treating tumor
GB201001521D0 (en) Treatment
GB0913968D0 (en) Treatment
GB0805912D0 (en) Treatment
GB0920933D0 (en) Agent for treating disease
GB0920942D0 (en) Agent for treating disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)